Hcw biologics showcases scientific paper in molecular therapy highlighting potential of hcw9218 as novel, bifunctional cancer immunotherapeutic

Lead drug candidate engineered using tissue factor-based fusion (tobi™) platform

HCWB Ratings Summary

HCWB Quant Ranking